Physics and AI Driven Precision Engineering of Novel Drugs

Health + Time : Priceless

We Engineer New Treatments Atom by Atom

To help you live healthier, longer

First-in-Class Drug Candidates to Change the Standard of Care for Every Disease We Address
More about our pipeline
Recent News
Our stories
Why AI alone won't resolve drug discovery challenges
"When it comes to drug discovery, AI has a data problem with which the pharmaceutical industry has not yet come to terms"
June 21, 2023
Exploring New Chemical Space for the Treatments of Tomorrow
We've seen the benefits of exploring entirely novel chemical entities... We are now entering an exciting new era in drug discovery and development with immense implications for human health.
June 1, 2023
AI in drug development: A reality check
"Existing data... is a small, little tiny pittance compared to the total number of possibilities that one could explore... Asking A.I. trained on that data to suddenly change everything... is more than just asking a lot. It's not possible."
May 25, 2023
Unlocking a Universe of Drug Candidates
Verseon's hybrid physics- and AI-based platform reveals possibilities far outside the Pharma industry's compound libraries
May 4, 2023
Dreaming Up Drugs No One Has Ever Seen
Verseon's physics- and AI-based drug discovery platform is expanding the frontiers of medicine
FEBRUARY 15, 2023
Disruptors Plan a New Dawn for Healthcare Technology
The Business Influencer describes how Verseon’s drug discovery platform is systematically tackling humanity’s major killers
FEBRUARY 3, 2023
What Will it Take for AI to Live Up to its Hype?
Adityo Prakash, CEO of Verseon, discusses how the data currently available to the pharma industry and other challenges limit AI’s ability to help discover novel drugs
JANUARY 31, 2023
Small Data, Big Ambitions
Verseon's combination of physics-based molecular modeling and Extreme Machine Learning promises multiple treatment options for patients who currently have none
JANUARY 11, 2023
Why AI alone won't resolve drug discovery challenges
"When it comes to drug discovery, AI has a data problem with which the pharmaceutical industry has not yet come to terms"
June 21, 2023
Exploring New Chemical Space for the Treatments of Tomorrow
We've seen the benefits of exploring entirely novel chemical entities... We are now entering an exciting new era in drug discovery and development with immense implications for human health.
June 1, 2023
AI in drug development: A reality check
"Existing data... is a small, little tiny pittance compared to the total number of possibilities that one could explore... Asking A.I. trained on that data to suddenly change everything... is more than just asking a lot. It's not possible."
May 25, 2023
Unlocking a Universe of Drug Candidates
Verseon's hybrid physics- and AI-based platform reveals possibilities far outside the Pharma industry's compound libraries
May 4, 2023
Dreaming Up Drugs No One Has Ever Seen
Verseon's physics- and AI-based drug discovery platform is expanding the frontiers of medicine
FEBRUARY 15, 2023
Disruptors Plan a New Dawn for Healthcare Technology
The Business Influencer describes how Verseon’s drug discovery platform is systematically tackling humanity’s major killers
FEBRUARY 3, 2023
What Will it Take for AI to Live Up to its Hype?
Adityo Prakash, CEO of Verseon, discusses how the data currently available to the pharma industry and other challenges limit AI’s ability to help discover novel drugs
JANUARY 31, 2023
Small Data, Big Ambitions
Verseon's combination of physics-based molecular modeling and Extreme Machine Learning promises multiple treatment options for patients who currently have none
JANUARY 11, 2023
More News
Changing everything the world can expect from 21st Century Medicine
Continue to Company